From the start [referring to slide], well, here is a chart showing the number of publications on pharmacogenetics from the 1960s to the present [the chart shows a gradual increase from the 1960s to mid 1990s, and then a sharp increase from the mid1990s to the present]. [...] It might turn out that the right drug for me is not the right drug for you – or that we might need to change the amount of the dosage. [...] If you can screen a patient group, you can find the patients that react well to a drug – and that means that a drug that would have otherwise been removed from the market due to the fact that some people experienced side effects... [...] The nice thing is that you really don’t even have to do a genetic test – you can just do a blood sample test to discover a sign that this patient breaks it down slowly, he should be taking a dose that is one-tenth of the normal dosage. [...] Where do you expect to see the first examples of this kind of debate? A: Although there are treatments like enhancing regeneration – which would be really great for doping – that are going to appear in a few years, they are not going to be the source of the really big debates.
- Pages
- 19
- Published in
- Belgium
